Dr. Baldwin is William Rand Kenan Professor and Associate Director at the Lineberger Cancer Center of the University of North Carolina at Chapel Hill. He is widely recognized as one of the world's leaders in the field of NF-B biology.
Contact Dr. Baldwin at (919) 966-3652.

View biography

Sankar Ghosh, PhD

View biography

Max Wallace, JD

Mr. Wallace founded several notable biotechnology companies, including Sphinx Pharmaceuticals (acquired by Eli Lilly & Co.), Trimeris (TRMS on the NASDAQ exchange), SARCO (acquired by PPD Pharmaco) and Cogent Neuroscience. He also held various positions at Duke University, including serving as Medical Center Counsel and as a founding director of Duke University's investment management company.
Contact Mr. Wallace at (919) 368-2435

Sergei Makarov, PhD

Dr. Makarov is the founder and CEO of the transcription factor profiling company, Attagene. Prior to founding Attagene, Dr. Makarov served as an Associate Professor in the School of Dentistry at the University of North Carolina at Chapel Hill. He has worked extensively in the field of NF-B regulation.
Contact Dr. Makarov at (919) 313-0167

Daniel Ricca, PhD

Dr. Ricca was a co-founder of SARCO, a combinatorial chemistry and drug discovery company acquired by PPD Pharmaco. He served as a research chemist in the Glaxo Research Institute and in senior chemistry management positions in PPD Discovery, Cogent Neuroscience and Dynogen.
Contact Dr. Ricca at (919) 732-7339

Patrick Flood, PhD

Dr. Flood is Associate Professor in the School of Dentistry at the University of North Carolina at Chapel Hill; he serves as the Director of the University's Comprehensive Center for Inflammatory Disorders; and he is also a member of the University's Lineberger Comprehensive Cancer Center.
Contact Dr. Flood at (919) 966-1538